Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs
AK Singh, R Singh - Expert review of clinical pharmacology, 2020 - Taylor & Francis
Introduction: Obesity poses a significant increase in morbidity and mortality and thus five anti-
obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown …
obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown …
Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs
AK Singh, R Singh - Expert review of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction: Obesity poses a significant increase in morbidity and mortality and thus five anti-
obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown …
obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown …
Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs.
AK Singh, R Singh - Expert Review of Clinical Pharmacology, 2019 - europepmc.org
Introduction: Obesity poses a significant increase in morbidity and mortality and thus five anti-
obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown …
obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown …
[PDF][PDF] Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs
AK Singh, R Singh - 2019 - researchgate.net
Introduction: Obesity poses a significant increase in morbidity and mortality and thus five anti-
obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown …
obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown …